305 related articles for article (PubMed ID: 30930440)
21. Development of Bilayer Tablets with Modified Release of Selected Incompatible Drugs.
Dhiman N; Awasthi R; Jindal S; Khatri S; Dua K
Polim Med; 2016; 46(1):5-15. PubMed ID: 28397414
[TBL] [Abstract][Full Text] [Related]
22. Dissolution and assaying of multicomponent tablets by chemometric methods using computer-aided spectrophotometer.
Dinç E; Serin C; Tuğcu-Demiröz F; Doğanay T
Int J Pharm; 2003 Jan; 250(2):339-50. PubMed ID: 12527161
[TBL] [Abstract][Full Text] [Related]
23. Dissolution testing of acetylsalicylic acid by a channel flow method-correlation to USP basket and intrinsic dissolution methods.
Peltonen L; Liljeroth P; Heikkilä T; Kontturi K; Hirvonen J
Eur J Pharm Sci; 2003 Aug; 19(5):395-401. PubMed ID: 12907290
[TBL] [Abstract][Full Text] [Related]
24. Prediction of tablet hardness based on near infrared spectra of raw mixed powders by chemometrics.
Otsuka M; Yamane I
J Pharm Sci; 2006 Jul; 95(7):1425-33. PubMed ID: 16721793
[TBL] [Abstract][Full Text] [Related]
25. Relationships between response surfaces for tablet characteristics of placebo and API-containing tablets manufactured by direct compression method.
Hayashi Y; Tsuji T; Shirotori K; Oishi T; Kosugi A; Kumada S; Hirai D; Takayama K; Onuki Y
Int J Pharm; 2017 Oct; 532(1):82-89. PubMed ID: 28859939
[TBL] [Abstract][Full Text] [Related]
26. Multispectral UV imaging for fast and non-destructive quality control of chemical and physical tablet attributes.
Klukkert M; Wu JX; Rantanen J; Carstensen JM; Rades T; Leopold CS
Eur J Pharm Sci; 2016 Jul; 90():85-95. PubMed ID: 26657202
[TBL] [Abstract][Full Text] [Related]
27. Development of a Physiologically Relevant Population Pharmacokinetic in Vitro-in Vivo Correlation Approach for Designing Extended-Release Oral Dosage Formulation.
Kim TH; Shin S; Bulitta JB; Youn YS; Yoo SD; Shin BS
Mol Pharm; 2017 Jan; 14(1):53-65. PubMed ID: 27809538
[TBL] [Abstract][Full Text] [Related]
28. Sustained release dosage forms dissolution behavior prediction: a study of matrix tablets using NIR spectroscopy.
Tabasi SH; Moolchandani V; Fahmy R; Hoag SW
Int J Pharm; 2009 Dec; 382(1-2):1-6. PubMed ID: 19660535
[TBL] [Abstract][Full Text] [Related]
29. Dissolution of tablet-in-tablet formulations studied with ATR-FTIR spectroscopic imaging.
Wray PS; Clarke GS; Kazarian SG
Eur J Pharm Sci; 2013 Mar; 48(4-5):748-57. PubMed ID: 23291036
[TBL] [Abstract][Full Text] [Related]
30. Mechanistic Approach to Understanding the Influence of USP Apparatus I and II on Dissolution Kinetics of Tablets with Different Operating Release Mechanisms.
Lu Z; Fassihi R
AAPS PharmSciTech; 2017 Feb; 18(2):462-472. PubMed ID: 27106916
[TBL] [Abstract][Full Text] [Related]
31. Effect of lignin on the release rate of acetylsalicylic acid tablets.
Pishnamazi M; Iqbal J; Shirazian S; Walker GM; Collins MN
Int J Biol Macromol; 2019 Mar; 124():354-359. PubMed ID: 30448498
[TBL] [Abstract][Full Text] [Related]
32. Using scattering and absorption spectra as MCR-hard model constraints for diffuse reflectance measurements of tablets.
Kessler W; Oelkrug D; Kessler R
Anal Chim Acta; 2009 May; 642(1-2):127-34. PubMed ID: 19427467
[TBL] [Abstract][Full Text] [Related]
33. Dissolution assessment of allopurinol immediate release tablets by near infrared spectroscopy.
Smetiško J; Miljanić S
J Pharm Biomed Anal; 2017 Oct; 145():322-330. PubMed ID: 28709129
[TBL] [Abstract][Full Text] [Related]
34. Dissolution Studies of Papaverine Hydrochloride from Tablets in Three Pharmacopoeia Apparatuses.
Polski A; Kasperek R; Rogowska M; Iwaniak K; Sobòtka-Polska K; Poleszak E
Polim Med; 2015; 45(1):21-4. PubMed ID: 26630725
[TBL] [Abstract][Full Text] [Related]
35. High-throughput NIR-chemometric methods for chemical and pharmaceutical characterization of sustained release tablets.
Porfire A; Filip C; Tomuta I
J Pharm Biomed Anal; 2017 May; 138():1-13. PubMed ID: 28171787
[TBL] [Abstract][Full Text] [Related]
36. Simultaneous determination of nicotinamide, pyridoxine hydrochloride, thiamine mononitrate and riboflavin in multivitamin with minerals tablets by reversed-phase ion-pair high performance liquid chromatography.
Li K
Biomed Chromatogr; 2002 Dec; 16(8):504-7. PubMed ID: 12474212
[TBL] [Abstract][Full Text] [Related]
37. Design of fixed dose combination and physicochemical characterization of enteric-coated bilayer tablet with circadian rhythmic variations containing telmisartan and pravastatin sodium.
Luo D; Kim JH; Park C; Oh E; Park JB; Cui JH; Cao QR; Lee BJ
Int J Pharm; 2017 May; 523(1):343-356. PubMed ID: 28330645
[TBL] [Abstract][Full Text] [Related]
38. In-line monitoring of the drug content of powder mixtures and tablets by near-infrared spectroscopy during the continuous direct compression tableting process.
Järvinen K; Hoehe W; Järvinen M; Poutiainen S; Juuti M; Borchert S
Eur J Pharm Sci; 2013 Mar; 48(4-5):680-8. PubMed ID: 23313622
[TBL] [Abstract][Full Text] [Related]
39. Abnormal dissolutions of chlorpromazine hydrochloride tablets in water by paddle method under a high agitation condition.
Aoyagi N; Rimando AP; Izutsu K; Katori N; Kojima S
Chem Pharm Bull (Tokyo); 2003 Sep; 51(9):1021-4. PubMed ID: 12951441
[TBL] [Abstract][Full Text] [Related]
40. [Simultaneous quantitative determination of multicomponents in tablets based on terahertz time-domain spectroscopy].
Chen T; Li Z; Mo W; Hu FR
Guang Pu Xue Yu Guang Pu Fen Xi; 2013 May; 33(5):1220-5. PubMed ID: 23905323
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
